Genenta Science

Genenta is a clinical-stage biotechnology company that is pioneering the development of proprietary hematopoietic stem cell gene therapies for the treatment of various solid tumor cancers. Temferon™ is based on ex vivo gene transfer to autologous hematopoietic stem/progenitor cells (HSPC) to directly deliver immunomodulatory molecules through tumor-infiltrating monocytes/macrophages (Tie2-expressing monocytes - TEM).